Title:
AGENT FOR PREVENTING OR IMPROVING NYCTURIA
Document Type and Number:
WIPO Patent Application WO/2019/230626
Kind Code:
A1
Abstract:
Provided is an agent for preventing or improving nycturia, said agent containing rosmarinic acid or a salt thereof as an active ingredient.
Inventors:
KITAMURA NAOYA (JP)
Application Number:
PCT/JP2019/020831
Publication Date:
December 05, 2019
Filing Date:
May 27, 2019
Export Citation:
Assignee:
KAO CORP (JP)
International Classes:
A61K31/222; A61K36/535; A61P7/12
Domestic Patent References:
| WO2006020994A2 | 2006-02-23 |
Foreign References:
| JP2017052747A | 2017-03-16 | |||
| JP2013216592A | 2013-10-24 | |||
| JP2017052747A | 2017-03-16 | |||
| JPH0129558B2 | 1989-06-12 | |||
| JP2018101411A | 2018-06-28 |
Other References:
KWON, Y. 0. ET AL.: "Rosmarinic acid potentiates pentobarbital-induced sleep behaviors and non- rapid eye movement (NREM) sleep through the activation of GABAA-ergic systems", BIOMOLECULES & THERAPEUTICS, vol. 25, no. 2, March 2017 (2017-03-01), pages 105 - 111, XP053036961
KITAMURA, NAOYA ET AL.: "Perilla extract improves frequent urination in spontaneously hypertensive rats with enhancement of the urothelial presence and anti-inflammatory effects", INTERNATIONAL JOURNAL OF UROLOGY, vol. 25, no. 3, 21 December 2017 (2017-12-21) - March 2018 (2018-03-01), pages 298 - 304, XP055662627
JAPAN UROLOGICAL ASSOCIATION, JOURNAL OF THE WEST, vol. 68, 2006, pages 51 - 54
EUROPEAN UROLOGY, vol. 62, 2012, pages 1040 - 1060
TISSUE CELL, vol. 43, 2011, pages 392 - 397
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, vol. 110, 2012, pages 390 - 395
EUROPEAN JOURNAL OF NUTRITION, vol. 44, 2005, pages 1 - 9
PLANTA MEDICA, vol. 82, 2016, pages 388 - 406
AMERICAN JOURNAL OF PHYSIOLOGY, vol. 275, 1998, pages R1279 - 1286
NEUROUROLOGY AND URODYNAMICS, vol. 24, 2005, pages 295 - 300
NEUROUROLOGY AND URODYNAMICS, vol. 36, 2017, pages 1034 - 1038
See also references of EP 3804710A4
KITAMURA, NAOYA ET AL.: "Perilla extract improves frequent urination in spontaneously hypertensive rats with enhancement of the urothelial presence and anti-inflammatory effects", INTERNATIONAL JOURNAL OF UROLOGY, vol. 25, no. 3, 21 December 2017 (2017-12-21) - March 2018 (2018-03-01), pages 298 - 304, XP055662627
JAPAN UROLOGICAL ASSOCIATION, JOURNAL OF THE WEST, vol. 68, 2006, pages 51 - 54
EUROPEAN UROLOGY, vol. 62, 2012, pages 1040 - 1060
TISSUE CELL, vol. 43, 2011, pages 392 - 397
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, vol. 110, 2012, pages 390 - 395
EUROPEAN JOURNAL OF NUTRITION, vol. 44, 2005, pages 1 - 9
PLANTA MEDICA, vol. 82, 2016, pages 388 - 406
AMERICAN JOURNAL OF PHYSIOLOGY, vol. 275, 1998, pages R1279 - 1286
NEUROUROLOGY AND URODYNAMICS, vol. 24, 2005, pages 295 - 300
NEUROUROLOGY AND URODYNAMICS, vol. 36, 2017, pages 1034 - 1038
See also references of EP 3804710A4
Attorney, Agent or Firm:
IIDA & PARTNERS et al. (JP)
Download PDF: